User menu

DW-MRI and (18) F-FLT PET for early assessment of response to radiation therapy associated with hypoxia-driven interventions. Preclinical studies using manipulation of oxygenation and/or dose escalation

Bibliographic reference Tran, Ly Binh An ; Bol, Anne ; Labar, Daniel ; Karroum, Oussama ; Mignion, Lionel ; et. al. DW-MRI and (18) F-FLT PET for early assessment of response to radiation therapy associated with hypoxia-driven interventions. Preclinical studies using manipulation of oxygenation and/or dose escalation. In: Contrast Media & Molecular Imaging, Vol. 11, no.2, p. 115-121 (2016)
Permanent URL
  1. Therasse Patrick, Arbuck Susan G., Eisenhauer Elizabeth A., Wanders Jantien, Kaplan Richard S., Rubinstein Larry, Verweij Jaap, Van Glabbeke Martine, van Oosterom Allan T., Christian Michaele C., Gwyther Steve G., New Guidelines to Evaluate the Response to Treatment in Solid Tumors, 10.1093/jnci/92.3.205
  2. Rudin Markus, Imaging readouts as biomarkers or surrogate parameters for the assessment of therapeutic interventions, 10.1007/s00330-007-0619-9
  3. Padhani, Neoplasia, 11, 102 (2009)
  4. Patterson Daniel M, Padhani Anwar R, Collins David J, Technology Insight: water diffusion MRI—a potential new biomarker of response to cancer therapy, 10.1038/ncponc1073
  5. Moestue Siver A., Huuse Else M., Lindholm Evita M., Bofin Anna, Engebraaten Olav, Maelandsmo Gunhild M., Akslen Lars A., Gribbestad Ingrid S., Low-molecular contrast agent dynamic contrast-enhanced (DCE)-MRI and diffusion-weighted (DW)-MRI in early assessment of bevacizumab treatment in breast cancer xenografts : MRI of Bevacizumab-Treated Xenografts, 10.1002/jmri.24079
  6. Musio Daniela, De Felice Francesca, Magnante Anna Lisa, Ciolina Maria, De Cecco Carlo Nicola, Rengo Marco, Redler Adriano, Laghi Andrea, Raffetto Nicola, Tombolini Vincenzo, Diffusion-Weighted Magnetic Resonance Application in Response Prediction before, during, and after Neoadjuvant Radiochemotherapy in Primary Rectal Cancer Carcinoma, 10.1155/2013/740195
  7. Koh, Am J Roentgenol, 188, 1622 (2007)
  8. Hamstra Daniel A., Rehemtulla Alnawaz, Ross Brian D., Diffusion Magnetic Resonance Imaging: A Biomarker for Treatment Response in Oncology, 10.1200/jco.2007.11.9610
  9. Salskov Alexander, Tammisetti Varaha S., Grierson John, Vesselle Hubert, FLT: Measuring Tumor Cell Proliferation In Vivo With Positron Emission Tomography and 3′-Deoxy-3′-[18F]Fluorothymidine, 10.1053/j.semnuclmed.2007.08.001
  10. Bading J. R., Shields A. F., Imaging of Cell Proliferation: Status and Prospects, 10.2967/jnumed.107.046391
  11. Shields Anthony F., Grierson John R., Dohmen Bernhard M., Machulla H.-Juergen, Stayanoff Joseph C., Lawhorn-Crews Jawana M., Obradovich Joyce E., Muzik Otto, Mangner Thomas J., Imaging proliferation in vivo with [F-18]FLT and positron emission tomography, 10.1038/3337
  12. Contractor K. B., Kenny L. M., Stebbing J., Rosso L., Ahmad R., Jacob J., Challapalli A., Turkheimer F., Al-Nahhas A., Sharma R., Coombes R. C., Aboagye E. O., [18F]-3'Deoxy-3'-Fluorothymidine Positron Emission Tomography and Breast Cancer Response to Docetaxel, 10.1158/1078-0432.ccr-11-0783
  13. Kenny L. M., Contractor K. B., Stebbing J., Al-Nahhas A., Palmieri C., Shousha S., Coombes R. C., Aboagye E. O., Altered Tissue 3'-Deoxy-3'-[18F]Fluorothymidine Pharmacokinetics in Human Breast Cancer following Capecitabine Treatment Detected by Positron Emission Tomography, 10.1158/1078-0432.ccr-09-1213
  14. Sohn H.-J., Yang Y.-J., Ryu J.-S., Oh S. J., Im K. C., Moon D. H., Lee D. H., Suh C., Lee J.-S., Kim S.-W., [18F]Fluorothymidine Positron Emission Tomography before and 7 Days after Gefitinib Treatment Predicts Response in Patients with Advanced Adenocarcinoma of the Lung, 10.1158/1078-0432.ccr-08-0312
  15. Chen Wei, Delaloye Sibylle, Silverman Daniel H.S., Geist Cheri, Czernin Johannes, Sayre James, Satyamurthy Nagichettiar, Pope Whitney, Lai Albert, Phelps Michael E., Cloughesy Timothy, Predicting Treatment Response of Malignant Gliomas to Bevacizumab and Irinotecan by Imaging Proliferation With [18F] Fluorothymidine Positron Emission Tomography: A Pilot Study, 10.1200/jco.2006.10.5825
  16. Yang You-Jung, Ryu Jin-Sook, Kim Seog-Young, Oh Seung Jun, Im Ki Chun, Lee Heuiran, Lee Sang-wook, Cho Kyung Ja, Cheon Gi-Jeong, Moon Dae Hyuk, Use of 3′-deoxy-3′-[18F]fluorothymidine PET to monitor early responses to radiation therapy in murine SCCVII tumors, 10.1007/s00259-005-0011-4
  17. Hoeben B. A. W., Troost E. G. C., Span P. N., van Herpen C. M. L., Bussink J., Oyen W. J. G., Kaanders J. H. A. M., 18F-FLT PET During Radiotherapy or Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma Is an Early Predictor of Outcome, 10.2967/jnumed.112.105999
  18. Apisarnthanarax S., Alauddin M. M., Mourtada F., Ariga H., Raju U., Mawlawi O., Han D., Bornmann W. G., Ajani J. A., Milas L., Gelovani J. G., Chao K.S. C., Early Detection of Chemoradioresponse in Esophageal Carcinoma by 3'-Deoxy-3'-3H-Fluorothymidine Using Preclinical Tumor Models, 10.1158/1078-0432.ccr-05-2720
  19. Nordsmark Marianne, Bentzen Søren M., Rudat Volker, Brizel David, Lartigau Eric, Stadler Peter, Becker Axel, Adam Markus, Molls Michael, Dunst Juergen, Terris David J., Overgaard Jens, Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study, 10.1016/j.radonc.2005.06.038
  20. Gray L. H., Conger A. D., Ebert M., Hornsey S., Scott O. C. A., The Concentration of Oxygen Dissolved in Tissues at the Time of Irradiation as a Factor in Radiotherapy, 10.1259/0007-1285-26-312-638
  21. Harrison L. B., Impact of Tumor Hypoxia and Anemia on Radiation Therapy Outcomes, 10.1634/theoncologist.7-6-492
  22. Horsman Michael, Wouters Bradly, Joiner Michael, Overgaard Jens, The oxygen effect and fractionated radiotherapy, Basic Clinical Radiobiology Fourth Edition (2009) ISBN:9780340929667 p.207-216, 10.1201/b13224-16
  23. Toma-Dasu Iuliana, Uhrdin Johan, Antonovic Laura, Dasu Alexandru, Nuyts Sandra, Dirix Piet, Haustermans Karin, Brahme Anders, Dose prescription and treatment planning based on FMISO-PET hypoxia, 10.3109/0284186x.2011.599815
  24. Bentzen Søren M., Gregoire Vincent, Molecular Imaging–Based Dose Painting: A Novel Paradigm for Radiation Therapy Prescription, 10.1016/j.semradonc.2010.10.001
  25. Hendrickson Kristi, Phillips Mark, Smith Wade, Peterson Lanell, Krohn Kenneth, Rajendran Joseph, Hypoxia imaging with [F-18] FMISO-PET in head and neck cancer: Potential for guiding intensity modulated radiation therapy in overcoming hypoxia-induced treatment resistance, 10.1016/j.radonc.2011.07.029
  26. Walsh Joseph C., Lebedev Artem, Aten Edward, Madsen Kathleen, Marciano Liane, Kolb Hartmuth C., The Clinical Importance of Assessing Tumor Hypoxia: Relationship of Tumor Hypoxia to Prognosis and Therapeutic Opportunities, 10.1089/ars.2013.5378
  27. Vaupel Peter, Kelleher DebraK, Thews Oliver, Modulation of tumor oxygenation, 10.1016/s0360-3016(98)00324-1
  28. Bernier Jacques, Denekamp Juliana, Rojas Anamaria, Minatel Emilio, Horiot Jean-Claude, Hamers Han, Antognoni Paolo, Dahl Olav, Richaud Pierre, van Glabbeke Martine, Piérart Marianne, ARCON: accelerated radiotherapy with carbogen and nicotinamide in head and neck squamous cell carcinomas. The experience of the Co-operative Group of Radiotherapy of the European Organization for Research and Treatment of Cancer (EORTC), 10.1016/s0167-8140(00)00165-1
  29. Tran Ly-Binh-An, Bol Anne, Labar Daniel, Karroum Oussama, Bol Vanesa, Jordan Bénédicte, Grégoire Vincent, Gallez Bernard, Potential role of hypoxia imaging using 18F-FAZA PET to guide hypoxia-driven interventions (carbogen breathing or dose escalation) in radiation therapy, 10.1016/j.radonc.2014.09.016
  30. Padhani Anwar R., Liu Guoying, Mu-Koh Dow, Chenevert Thomas L., Thoeny Harriet C., Takahara Taro, Dzik-Jurasz Andrew, Ross Brian D., Van Cauteren Marc, Collins David, Hammoud Dima A., Rustin Gordon J.S., Taouli Bachir, Choyke Peter L., Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations, 10.1593/neo.81328
  31. Koh Dow-Mu, Collins David J., Diffusion-Weighted MRI in the Body: Applications and Challenges in Oncology, 10.2214/ajr.06.1403
  32. Schwartz, J Nucl Med, 44, 2027 (2003)
  33. Shields A. F., PET Imaging of Tumor Growth: Not as Easy as It Looks, 10.1158/1078-0432.ccr-11-3198
  34. Schelhaas S., Wachsmuth L., Viel T., Honess D. J., Heinzmann K., Smith D.-M., Hermann S., Wagner S., Kuhlmann M. T., Muller-Tidow C., Kopka K., Schober O., Schafers M., Schneider R., Aboagye E. O., Griffiths J., Faber C., Jacobs A. H., Variability of Proliferation and Diffusion in Different Lung Cancer Models as Measured by 3'-Deoxy-3'-18F-Fluorothymidine PET and Diffusion-Weighted MR Imaging, 10.2967/jnumed.113.133348
  35. Kim Il Han, Martin Brown J., Reoxygenation and rehypoxiation in the SCCVII mouse tumor, 10.1016/0360-3016(94)90444-8
  36. Baumann Michael, Krause Mechthild, Hill Richard, Exploring the role of cancer stem cells in radioresistance, 10.1038/nrc2419
  37. Bussink Johan, van Herpen Carla ML, Kaanders Johannes HAM, Oyen Wim JG, PET-CT for response assessment and treatment adaptation in head and neck cancer, 10.1016/s1470-2045(09)70353-5
  38. Landuyt Willy, Ahmed Bisan, Nuyts Sandra, Theys Jan, Op de Beeck Michel, Rijnders Alex, Anné Jozef, Oosterom Allan van, Van den Bogaert Walter, Lambin Philippe, In vivo antitumor effect of vascular targeting combined with either ionizing radiation or anti-angiogenesis treatment, 10.1016/s0360-3016(00)01470-x
  39. Yun Mikyung, Oh Seung Jun, Ha Hyun-Joon, Ryu Jin Sook, Moon Dae Hyuk, High radiochemical yield synthesis of 3′-deoxy-3′-[18F]fluorothymidine using (5′-O-dimethoxytrityl-2′-deoxy-3′-O-nosyl-β-D-threo pentofuranosyl)thymine and its 3-N-BOC-protected analogue as a labeling precursor, 10.1016/s0969-8051(02)00409-2